Mount Sinai Hospital has received investigator-initiated grant support from Amgen, Eli Lilly Inc., Novo Nordisk, Pfizer and Zealand Pharmaceuticals Inc
Evaluating glycemic control efficacy and safety of the oral small molecule glucagon-like peptide 1 receptor agonist danuglipron in type 2 diabetes patients: a systemic review and meta-analysis
What FeelGood shares with the broader compounded GLP-1 telehealth category is the regulatory context: compounded medications aren't FDA-approved
On February 20, 2026, the FDA issued warning letter #721455 to MEDVi, LLC
Novo Nordisk, the maker of Ozempic, also sells another semaglutide known as Wegovy
Semaglutide, on the other hand, is over 4000 Daltons and is unlikely to be absorbed through the skin 7